A. Turner

Is HIV infection a risk factor for leprosy?

J. Sterne, P. Fine, P. Fine, 1991, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.

Testing for antibody to human immunodeficiency virus type 1 in a population in which mycobacterial diseases are endemic.

J. Sterne, J. Parry, P. Fine, 1995, The Journal of infectious diseases.

COMPARISONS OF THERAPEUTIC EFFECTS OF LEVODOPA, LEVODOPA AND SELEGILINE, AND BROMOCRIPTINE IN PATIENTS WITH EARLY, MILD PARKINSONS-DISEASE - 3-YEAR INTERIM-REPORT

C. Marsden, C. Kennard, L. Illis, 1993 .

Setting up HIV serology for the Karonga leprosy vaccine trial in Malaŵi.

J. Blackwell, P. Fine, P. Fine, 1991, Leprosy review.

Transient or occult HIV infections may occur more frequently than progressive infections: changing the paradigm about HIV persistence.

S. Weaver, S. Baron, T. McNearney, 2005, Archives of virology. Supplementum.

Comparison of False‐Positive Reactions in Direct‐Binding Anti‐HIV ELISA Using Cell Lysate or Recombinant Antigens

E. Love, V. Martlew, H. Gunson, 1990, Vox sanguinis.

Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire.

P. Piot, P. van der Stuyft, R. Ryder, 1990, The Journal of infection.

Surveillance for the impact in the UK of HIV epidemics in South Asia.

J. Parry, A. Nicoll, A. Turner, 1999, Ethnicity & health.

Infection with human immunodeficiency virus type 1 among leprosy patients in Zaire.

J. Sterne, P. Fine, K. D. de Cock, 1995, The Journal of infectious diseases.

Human immunodeficiency virus: GACPAT and GACELISA as diagnostic tests for antibodies in urine.

J. Sterne, J. Parry, P. Fine, 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.